First evaluations of oxygen-ozone therapy in antibiotic-resistant infections

Abstract

Acquired antibiotic resistance represents one of the main restrictions to an effective antibacterial chemotherapy. The continuous growth of the phenomenon draws a therapeutical problem to eradicate infections. Ozone presents known properties, such as antibacterial, antiviral, anti-fungal, anti-inflammatory, analgesic, immunomodulation, and reactivation of microcirculation. Oxygen-ozone therapy has no collateral effects, it is minimally invasive, it is not painful and it does not cause allergic or toxic reactions or drug-drug interactions. Therefore, oxygen-ozone therapy has proved to be useful to control and run out infections in patients with a noted antimicrobial resistant pathology. We are evaluating the best protocol to treat these pathologies, to obtain the most efficient therapeutical response.